McKesson Corporation (MCK) key performance indicators and operating metrics (31 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Medical-Surgical Solutions revenues | 2.82B | FY2027-Q1 |
| Prescription Technology Solutions revenues | 1.58B | FY2027-Q1 |
| Prescription Technology Solutions segment operating profit | 226M | FY2027-Q1 |
| Medical-Surgical Solutions adjusted segment operating profit | 195M | FY2027-Q1 |
| Prescription Technology Solutions adjusted segment operating profit | 303M | FY2027-Q1 |
| Medical-Surgical Solutions segment operating profit | 122M | FY2027-Q1 |
| Adjusted earnings per diluted share | 9.93 USD_per_share | FY2027-Q1 |
| North American Pharmaceutical adjusted segment operating profit | 894M | FY2027-Q1 |
| North American Pharmaceutical segment revenues | 86.79B | FY2027-Q1 |
| Oncology and Multispecialty adjusted segment operating profit | 405M | FY2027-Q1 |
| Oncology and Multispecialty segment revenues | 14.21B | FY2027-Q1 |
| Oncology and Multispecialty segment operating profit | 325M | FY2027-Q1 |
| North American Pharmaceutical segment operating profit | 903M | FY2027-Q1 |
| United States Pharmaceutical revenues | 89.95B | FY2026-Q1 |
Back to MCK overview · MCK earnings · MCK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.